Skip to content

EU Vaccine Strategy

Event date: 07/01/2021

EU Vaccine Strategy

Developing and deploying an effective and safe vaccine worldwide is likely to be the only way to end the COVID-19 pandemic. To this end, the Commission has proposed an EU vaccines strategy for COVID-19 and listed key steps for effective vaccination strategies and vaccine deployment.

The Commission has also entered into advance purchase agreements with several pharmaceutical laboratories in order to create a portfolio of potential vaccines against COVID-19 (Coronavirus). Any vaccine must be authorised by the European Medicines Agency (EMA) in accordance with safety and efficacy standards.

News history

MEPs debate the need for more clarity and transparency regarding vaccine contracts, authorisation, availability and deployment of COVID-19 vaccines.

Show only related media

Webstreaming (1)